Januvia Lawsuit & Pancreatic Cancer Information


Type 2 diabetes patients who use Januvia may be at an increased risk for pancreatitis and pancreatic cancer. A growing number of Januvia lawsuits allege that Merck & Co was aware of these dangers, but failed to provide adequate warnings to patients and doctors. Public Citizen, a prominent consumer advocacy watchdog, has even called on federal regulators to order a Januvia recall because of its association with pancreatitis and pancreatic cancer.

Bernstein Liebhard LLP is investigating Januvia lawsuits, and our attorneys would like to hear from anyone who has reason to suspect that this drug caused harm to themselves or a loved one. If you or someone you care about developed Januvia pancreatic cancer or pancreatitis, you may be able to collect compensation for your damages, including medical bills, lost wages, and pain and suffering. To learn more, please contact Bernstein Liebhard LLP today for a free Januvia lawsuit review with one of our experienced attorneys.

Januvia and Pancreatic Cancer

Januvia was approved by the U.S. Food & Drug Administration (FDA) in 2007 to treat type 2 diabetes. Januvia is an incretin mimetic, and works by mimicking the action of incretin, a hormone which occurs in the gut and triggers the pancreas to increase production of insulin. Other incretin mimetics currently approved for use in the U.S. include:

  • Byetta
  • Bydureon
  • Victoza
  • Janumet (Januvia + Metformin)
  • Janumet XR
  • Juvisync
  • Onglyza
  • Kombiglyze XR
  • Nesina
  • Kazano
  • Oseni
  • Tradjenta

The first hint that Januvia might have undesirable effects on the pancreas came in 2009, when the U.S. Food & Drug Administration (FDA) warned that it was aware of 88 post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis, that occurred in patients taking Januvia. According to the Januvia FDA warning, the agency had asked Merck & Co. to include new information on the drug’s label regarding Januvia pancreatitis.

In 2011, a study published in the journal Gastroenterology found that use of Januvia appeared to increase the risk of pancreatitis by as much as six-fold. The same study also reported a risk of Januvia pancreatic cancer after finding the drug increased the likelihood for the disease by more than two-fold.

The FDA announced an investigation of Januvia and other incretin mimetics in March 2013, after an unpublished study indicated that use of these medications may cause precancerous changes to the cells of the pancreas.

Pancreatic cancer ranks among the most deadly forms of cancer, so it’s important that patients taking Januvia understand the warning signs that might be associated with this disease.  Some possible symptoms of Januvia pancreatic cancer include:

  • dark urine
  • light-colored stools
  • fatigue and weakness
  • jaundice
  • loss of appetite
  • weight loss
  • nausea and vomiting
  • pain or discomfort in the upper part of the belly or abdomen that gets worse with eating

Has There Been a Januvia Recall?

At this time, the potential risk for Januvia pancreatitis and pancreatic cancer has not resulted in a recall. However, in March 2013 Public Citizen petitioned the FDA to pull Januvia from the market, after its analysis of the agency’s adverse event database revealed 292 reports of pancreatic tumors associated with Januvia and two other incretin drugs. The analysis also found that most of the patients involved in these reports did not have any other risk factors for pancreatic cancer, including alcohol abuse or a history of smoking. “The idea of putting a warning label about pancreatic cancer on drugs that have no unique benefit for diabetics… would be an extraordinarily reckless approach for the FDA to initiate,” the group said in a statement.

Even though no Januvia recall has been announced, victims of Januvia pancreatic cancer and Januvia pancreatitis may still be entitled to compensation from Merck & Co.  Bernstein Liebhard LLP has successfully represented hundreds of people injured by defective drugs and medical devices, and our Januvia attorneys will do everything possible to ensure you are treated fairly. For a free Januvia lawsuit review, please contact our Firm today, at .

About Our Attorneys

Since 1993, our lawyers have recovered more than $3 billion on behalf of injured victims, including patients harmed by defective drugs and medical devices. Should you choose Bernstein Liebhard LLP to represent you in your lawsuit, you will have a highly experienced team of attorneys, paralegals and investigators on your side, all committed to protecting your legal rights and working to ensure your physical, emotional and financial recovery.